Position in MRK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$102,753,161
-$7,203,224 QoQ
Shares Held
854,212
-18.2% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 67.90433756491363.ToString("F0")%
Shared 0.ToString("F0")%
None 32.09566243508637.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $1,766,978,720 across 8 Drug Manufacturers - General names. MRK ranks #2 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,421,749 | $1,463,717,337 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
854,212 | $102,753,161 | |
| 3 | PFE |
Pfizer Inc
|
1,914,219 | $53,751,269 | |
| 4 | BIIB |
Biogen Inc.
|
280,783 | $51,475,947 | |
| 5 | SNY |
Sanofi
|
1,064,516 | $51,288,380 | |
| 6 | NVO |
Novo Nordisk A S
|
1,174,213 | $43,152,327 | |
| 7 | GSK |
GSK plc
|
11,110 | $613,160 | |
| 8 | NVS |
Novartis AG
|
1,487 | $227,139 |
All Filings in MRK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102,753,161 | 854,212 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $109,956,385 | 1,044,617 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $95,181,404 | 1,134,057 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $77,787,365 | 982,660 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $80,592,721 | 897,869 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $58,143,374 | 584,473 | Shares | Sole | 2025-02-13 | |
| 2020-06-30 | $60,069,055 | 814,074 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $106,823,363 | 1,455,042 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||